Modeling Polypharmacy and Predicting Drug-Drug Interactions using Deep Generative Models on Multimodal Graphs
Nhat Khang Ngo, Truong Son Hy, Risi Kondor

TL;DR
This paper introduces a variational graph autoencoder approach that combines molecular fingerprints with latent node representations to improve drug-drug interaction prediction on multimodal networks.
Contribution
It presents a novel method integrating molecular fingerprints with variational graph autoencoders for enhanced link prediction in multimodal drug-related networks.
Findings
Achieved competitive results on three different multimodal networks.
Enhanced link prediction accuracy by combining molecular fingerprints with latent embeddings.
Demonstrated the effectiveness of flexible latent spaces in modeling complex drug interactions.
Abstract
Latent representations of drugs and their targets produced by contemporary graph autoencoder models have proved useful in predicting many types of node-pair interactions on large networks, including drug-drug, drug-target, and target-target interactions. However, most existing approaches model either the node's latent spaces in which node distributions are rigid or do not effectively capture the interrelations between drugs; these limitations hinder the methods from accurately predicting drug-pair interactions. In this paper, we present the effectiveness of variational graph autoencoders (VGAE) in modeling latent node representations on multimodal networks. Our approach can produce flexible latent spaces for each node type of the multimodal graph; the embeddings are used later for predicting links among node pairs under different edge types. To further enhance the models' performance,…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Code & Models
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsComputational Drug Discovery Methods · Cholinesterase and Neurodegenerative Diseases · Bioinformatics and Genomic Networks
